Regal Assets Analytics

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-10-20T14:21:50-04:00July 6th, 2020|Tags: , , , , , , , , , , , , , , , , |

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and webcast at 8 am Eastern on July 13, 2020, to [...]

Avadel Shares Stable After Nice Run; Cassava Shares Languish on Alzheimer’s Blues

By |2020-05-21T14:33:03-04:00May 18th, 2020|Tags: , |

Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial results for its drug FT218 to treat excessive daytime sleepiness [...]

Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020

By |2020-04-15T11:07:58-04:00April 15th, 2020|Tags: , , , , , , , , , |

Onconova Coverage suspended, Oragenics falls short in Phase II trial.   The FDA last week approved Acceleron Pharma Inc. (NASDAQ:XLRN) luspatercept [...]

Go to Top